0955-1731Level 3
OXALIPLATIN (oxaliplatin)
**Product type:** Human Prescription Drug
**Active ingredient:** OXALIPLATIN
**Strength:** 5 mg/mL
**Dosage form:** Injection, Solution, Concentrate
**Route:** Intravenous
**Labeler:** Winthrop U.S, a business of sanofi-aventis U.S. LLC
**Marketing category:** NDA AUTHORIZED GENERIC (NDA021759)
**Pharmacologic class:** Platinum-based Drug [EPC], Platinum-containing Compounds [EXT]
GET
/api/v1/systems/ndc_fda/nodes/0955-1731Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.